-+ 0.00%
-+ 0.00%
-+ 0.00%

Tonix Pharmaceuticals And Makana Therapeutics Announce Collaboration Combining Tonix's Anti-CD40L Monoclonal Antibody (TNX-1500) With Makana's Genetically Engineered Organs In Preclinical And Clinical Xenotransplantation Studies

Benzinga·04/09/2025 11:01:36
Listen to the news

Agreement includes the use of Tonix's TNX-1500, as part of an immunomodulatory regimen to reduce rejection of Makana's genetically engineered pig organs in xenotransplantation.